Showing 1 - 4 results of 4 for search 'Philip S Helliwell', query time: 0.02s
Refine Results
-
1
Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies by Philip J. Mease, Ana-Maria Orbai, Oliver FitzGerald, Mohamed Bedaiwi, Dona L. Fleishaker, Rajiv Mundayat, Pamela Young, Philip S. Helliwell
Published 2023-08-01
Article -
2
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis by Josef S Smolen, Laura C Coates, Eric Lespessailles, Mitsumasa Kishimoto, Rebecca Bolce, Andrew J Bradley, M. Elaine Husni, Joseph F. Merola, Lisa Macpherson, Philip S. Helliwell
Published 2022-11-01
Article -
3
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis... by Christopher T. Ritchlin, Atul Deodhar, Wolf‐Henning Boehncke, Enrique R. Soriano, Alexa P. Kollmeier, Xie L. Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S. Helliwell
Published 2023-03-01
Article -
4
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study by Laure Gossec, Peter Nash, Philip J Mease, Emmanouil Rampakakis, Laura C Coates, Philip S Helliwell, Alexa P Kollmeier, Xie L Xu, May Shawi, Miriam Zimmermann, Natalie J Shiff
Published 2024-03-01
Article